SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-094442
Filing Date
2021-03-25
Accepted
2021-03-25 16:11:00
Documents
3
Period of Report
2021-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d157405d8k.htm 8-K 18650
2 EX-99.1 d157405dex991.htm EX-99.1 38731
3 GRAPHIC g157405g61n22.jpg GRAPHIC 5736
  Complete submission text file 0001193125-21-094442.txt   66563
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38886 | Film No.: 21772470
SIC: 2834 Pharmaceutical Preparations